Abstract
Candida albicans is the most common pathogen that causes balanoposthitis. It often causes recurrence of symptoms probably due to its antifungal resistance. A significant number of balanitis Candida albicans isolates are resistant to azole and terbinafine antifungal agents in vitro. However, balanoposthitis caused by fluconazole- and terbinafine-resistant Candida albicans has rarely been reported. Here, we describe a case of a recurrent penile infection caused by fluconazole- and terbinafine-resistant Candida albicans, as well as the treatments administered to this patient. The isolate from the patient was tested for drug susceptibility in vitro. It was sensitive to itraconazole, voriconazole, clotrimazole and amphotericin B, but not to terbinafine and fluconazole. Thus, oral itraconazole was administrated to this patient with resistant Candida albicans penile infection. The symptoms were improved, and mycological examination result was negative. Follow-up treatment of this patient for 3 months showed no recurrence.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dockerty WG, Sonnex C. Candidal balano-posthitis: a study of diagnostic methods. Genitourin Med. 1995;71(6):407–9.
Alsterholm M, Flytström I, Leifsdottir R, et al. Frequency of bacteria, Candida and malassezia species in balanoposthitis. Acta Derm Venereol. 2008;88(4):331–6.
Lisboa C, Ferreira A, Resende C, Rodrigues AG. Infectious balanoposthitis: management, clinical and laboratory features. Int J Dermatol. 2009;48(2):121–4.
Hombalkar NN, Vaze D, Guha P, et al. Devastating penile mycosis leading to penile gangrene. Urology. 2013;82(3):704–6.
Li Bing-Kun, Wang Xiang, Ding Qiang. A case report of severe Aspergillus flavus penile infection. Asian J Androl. 2009;11(5):638–40.
Odds Frank C. In Candida albicans, resistance to flucytosine and terbinafine is linked to MAT locus homozygosity and multilocus sequence typing clade1. FEMS Yeast Res. 2009;9(7):1091–101.
Cernicka Jana, Subik Julius. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis. Int J Antimicrob Agents. 2006;27(5):403–8.
Seifi Z, Azish M, Salehi Z, et al. Candiduria in children and susceptibility patterns of recovered Candida species to antifungal drugs in Ahvaz. J Nephropathol. 2013;2(2):122–8.
Staniszewska M, Bondaryk M, Swoboda-Kopec E, et al. Candida albicans morphologies revealed by scanning electron microscopy analysis. Braz J Microbiol. 2013;44(3):813–21.
Yang Y, Hu Y, Zhang J, et al. A refractory case of chromoblastomycosis caused by Fonsecaea monorphora. Med Mycol. 2012;50(6):649–53.
Lee SC, Lee CW, Shih HJ, et al. Risk factors of mortality and comparative in vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia. J Microbiol Immunol Infect. 2014;47(3):245–53.
Perea S, López-Ribot JL, Kirkpatrick WR, et al. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 2001;45(10):2676–84.
Feng W, Yang J, Pan Y, Qiao Z, Ma Y. The correlation of virulence, pathogenicity, and itraconazole resistance with SAP activity in Candida albicans strains. Can J Microbiol. 2016;62(2):173–8.
Kirsch DR, Lai MH, O’Sullivan J. Isolation of the gene for cytochrome P450 L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans. Gene. 1988;68(2):229–37.
Andreassi L, Bilenchi R. Non-infectious inflammatory genital lesions. Clin Dermatol. 2014;32(2):307–14.
Mayser P. Mycotic infections of the penis. Andrologia. 1999;31(Suppl. l):13–6.
He L, Hao JH, Zhang JH, et al. Detection of minimum inhibitory concentration of 9 antifungal drugs to Candida albicans from Candidal balanoposthitis. Chin J Microecol. 2011;23(9):832–4 (Chinese).
Liu S, Hou Y, Chen X, et al. Combination of fluconazole with non-antifungal agents: A promising approach to cope with resistant Candida albicans infections and insight into new antifungal agent discovery. Int J Antimicrob Agents. 2014;43(5):395–402.
Eddouzi J, Parker JE, Vale-Silva LA, et al. Molecular mechanisms of drug resistance in clinical Candida species isolated from Tunisian hospitals. Antimicrob Agents Chemother. 2013;57(7):3182–93.
Pardini G, De Groot PW, Coste AT, et al. The CRH family coding for cell wall glycosylphosphatidylinositol proteins with a predicted transglycosidase domain affects cell wall organization and virulence of Candida albicans. J Biol Chem. 2006;281(52):40399–411.
Acknowledgments
This work was kindly supported by the Guangdong Natural Science Foundation (2015A030310035) and Guangdong Provincial Health Research Fund (A2013388).
We sincerely thank Dr. Mai Junhua for his assistance in English revision.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this paper.
Rights and permissions
About this article
Cite this article
Hu, Y., Hu, Y., Lu, Y. et al. A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans . Mycopathologia 182, 397–402 (2017). https://doi.org/10.1007/s11046-016-0070-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-016-0070-z